Utah-based Canyon Labs announces its strategic acquisition of Life Pack Labs in California, broadening its service offerings and enhancing its position as an industry leader in medical device and pharmaceutical compliance testing.

Amidst recent news on healthcare pricing, HTL-Strefa, part of the MTD Group, reinforces its commitment to delivering innovative, high-quality pen needles at lower costs, with the Droplet brand rapidly expanding across U.S. markets

Quasar Medical Is Expanding Its Capabilities By Adding Balloon Catheters

The Collaboration Aims to Address The Unmet Clinical Challenge Of Compromised Vision In Surgery

neurocare is pleased to announce that it has received FDA clearance for its industry-leading intermittent Theta Burst Stimulation (iTBS) protocol, available across its Apollo TMS Therapy System and other Transcranial Magnetic Stimulation systems for clinical practice.

Fresh financing to continue development of robust product portfolio and accelerate commercialization of Freyja’s VereSee Device to further innovation in fast-growing women’s health market

The science-based magazine cites sustained acoustic medicine as a noteworthy innovation for its ability to promote soft tissue healing anywhere, without restrictions of surgery or injections.

Enhanced Efficiency and Streamlined Workflows Empower Healthcare Professionals

The newest addition to the Fibrant product line

Freyja Healthcare Brings First-of-Its-Kind 2mm Abdominal-Access Device to Laparoscopic Surgery to Further Innovation in Fast-Growing Women’s Health Market

Droplet Micron is now indicated for the "subcutaneous injection of drugs," expanding its use beyond insulin to include medications such as GLP-1s, and more

DropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.

DropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ is designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.

Canyon Labs Hires Sales and Technical Business Development Leadership

Medical Device and Pharmaceutical Veterans Join Leadership of Canyon Labs to Bring Best-in-Class Customer Experience.

Priority Support on Speed Dial: Minicarm.com - The Partner You Can Always Count On

New Radiofrequency Treatment Reduces Fine Facial Lines and Wrinkles and Tightens Skin Through Soft Tissue Coagulation Without the Need for Consumables

Contract awarded for products that bring improvement to healthcare industry

Amazon Healthcare veteran Chris Holt brings experience and a bold vision to lead SoftWave TRT's market expansion and product innovation efforts.

CureSight™ Amblyopia treatment device named "Best New Technology Solution for Ophthalmology" for its innovation, impact, and market potential

New standards and means of communication to help ensure a more agile, transparent and robust U.S. healthcare supply chain

BIOINCYTE™ is a Next-Generation Autologous Fibrin and Platelet System

Stage Analytics commits to focused growth in Health Economics and Outcomes Research (HEOR), Legal Services, Innovation and Education, and Project Management Services

Nucleus Research publishes report highlighting results of increased revenue and reduced operating costs achieved by companies in the Network Security, Payments, and Medical Device industries after implementing Veloce CPQ

Award-winning company expands their U.S. warehouse with its high-quality Mini C-Arm refurbishment center.

American Heart Association consortium advances development of evidence-based health tech solutions.

BioDerm, Inc., a leading provider of disposable medical devices and wound care supplies, announced a new distribution deal with TillaCare Ltd, an Israeli designer and manufacturer of external urine collection devices.

Clinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators

Together the two companies will expand their reach and capabilities to better serve the Pharma and Biotech Industries

Agilis is looking forward to continued growth with Denise as the Principal Consultant to help clients achieve their regulatory goals and create safer medical products for the end users.